iRhythm Technologies Inc - Company Profile

Powered by

All the sales intelligence you need on iRhythm Technologies Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how iRhythm Technologies Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with iRhythm Technologies Inc.

Back to companies

iRhythm Technologies Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

iRhythm Technologies Inc (iRhythm) is a digital healthcare company. Its products include Zio Monitor System, a remote ECG monitoring system; Zio ECG Utilization Software System (ZEUS), to support the capture and analysis of ECG data. It also offers a mobile cardiac telemetry (MCT) monitoring system known as Zio AT; ZioSuite, which interprets reports, manages patients, and tracks patient monitors efficiently through a comprehensive web portal and mobile app; and MyZio patient app that helps patients with digital symptom logging, educational content, and reminders. Its products are offered to general cardiologists, electrophysiologists, primary care physicians, neurologists, and other physician specialists through sales representatives, field billing specialists, and customer experience representatives. iRhythm is headquartered in San Francisco, California, the US.

Gain a 360-degree view of iRhythm Technologies Inc and make more informed decisions for your business Gain a 360-degree view of iRhythm Technologies Inc and make more informed decisions for your business Learn more
Headquarters United States of America

Address 699 8th Street, Suite 600, San Francisco, California, 94103


Telephone 1 415 6325700

No of Employees 2,005

Industry Medical Equipment

Ticker Symbol & Exchange IRTC (NASD)

Revenue (2024) $747.1M 26.2% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ 60.7% (2024 vs 2023)

Market Cap* $4.0B

Net Profit Margin (2025) XYZ 68.9% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

iRhythm Technologies Inc premium industry data and analytics

30+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

3

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on iRhythm Technologies Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Remote ECG Monitoring System Web Portal Zio
ECG Utilization Software System Patient Monitoring Application ZUES
Mobile Cardiac Telemetry (MCG) Monitoring System ZioSuite
Understand iRhythm Technologies Inc portfolio and identify potential areas for collaboration Understand iRhythm Technologies Inc portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 Contracts/Agreements In July, the company entered into a partnership with Lucem Health to leverage predictive AI to help identify arrhythmias earlier in patient populations with a higher risk for arrhythmias.
2025 New Products/Services In May, the company introduced its Zio long-term continuous ECG monitoring (LTCM) system, commercially introduced in this market as the Zio ECG Recording and Analysis System in Japan.
2024 Regulatory Approval In October, the company received clearance from the U.S. Food and Drug Administration for its 510(k) submission related to prior design changes made to the Zio AT device through a letter to file.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters iRhythm Technologies Inc Medtronic Plc GE HealthCare Technologies Inc BardyDx Inc BioTelemetry Inc
Headquarters United States of America Ireland United States of America United States of America United States of America
City San Francisco Dublin Chicago Seattle Malvern
State/Province California - Illinois Washington Pennsylvania
No. of Employees 2,005 95,000 54,000 - -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Quentin S. Blackford Chief Executive Officer; Director; President Executive Board 2021 46
Daniel G. Wilson Chief Financial Officer Senior Management 2024 43
Brian Lawrence, PhD Chief Technology Officer; Executive Vice President Senior Management 2025 -
Patrick Murphy Chief Business Officer; Chief Legal Officer Senior Management 2023 46
Sumi Shrishrimal Chief Risk Officer; Executive Vice President Senior Management 2022 46
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into iRhythm Technologies Inc key executives to enhance your sales strategy Gain insight into iRhythm Technologies Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?